A BESS-T-Scan analysis of cDNA COL1A1 and COL1A2 obtained by RT-PCR derived from five patients with sporadic forms of ostegenesis imperfecta was performed. The study was done in four patients with type I and one patient with type III OI. The analysis revealed the presence of structural changes in two regions of cDNA COL1A1 in two patients. No quantitative changes referring to COL1A2 gene were noted in any patient. The above analysis was the first application of the BESS-T-Scan technique in a molecular diagnosis of OI. The applied method seems to be useful and fulfil the basic criteria of the screening method to detect and locate mutations.
Bernard M. P., Chu M. L., Myers J.C., Ramirez F., Eikenberry E.F., Prockop D.J. (1983). Nucleotides sequences of complementary deoxyribonucleic acid for the pro alpha 1 chain of human type I procollagen. Statistical evaluation of structures that are conserved during evolution. Biochemistry 22: 5213-5223.
Chu M. L., de Wet W., Bernard M., Ramirez F. (1985). Fine structural analysis of the human pro-alpha 1 (I) collagen gene. Promoter structure Alu I repeats and polymorphic transcripts. J. Biol. Chem. 260: 2315-2320.
Dalgleish R. (1997). The human type I collagen mutation database. Nucl. Acids Res. 25: 181-187.
Genovese C., Rowe D. (1987). Analysis of cytoplasmatic and nuclear messenger RNA in fibroblasts from patients with type I osteogenesis imperfecta. Methods Enzymol. 145: 223-235.
Genovese С., Brufsky A., Shapiro J., Rowe D. (1989). Detection of mutations in human type I collagen mRNA in osteogenesis imperfecta by indirect RNase protection. J. Biol. Chem. 264: 9632-9637.
Hawkins A.G., Hoffman M.L., Schanke T.J., Moan E. (1997). Simple, rapid, nucleotide-level characterization of sequence variation using the Bess-T-Scan mutation detection and localization kit. Epicentre Forum 2(2).
Pietrzyk J.J., Kruczek A., Kostyk E., Sucharski P., Piątkowska E. (1998). Molecular studies in osteogenesis imperfecta (OI). I. Clinical analysis of patients with osteogenesis imperfecta. J. Appl. Genet. 39: 331-348.
Rowe D.W., Shapiro J.R., Schlesinger S. (1985). Dimnished type I collagen synthesis and reduced alpha 1 (I) collagen messenger RNA in cultured fibroblasts from patients with dominantly inherited (type I) osteogenesis imperfecta. J. Clin. Invest. 76: 604-611.
Stover M.L., Primorac D., McKinstry M.B., Rowe D.W. (1993). Defective splicing of mRNA from one COL1A1 allele of type I collagen in nondeforming (type I ) osteogenesis imperfecta. J. Clin. Invest. 92: 1994-2002.
Sykes B., Oglivie D., Wordsworth P., Anderson J., Jones N. (1986). Osteogenesis imperfecta is linked to both type I collagen structural genes. Lancet II: 69-72.
Sykes B., Oglivie D., Wordsworth P., Wallis G., Mathew C., Beighton P., Nicholls A., Pope F.M., Thompson E., Tsipouras P., Schwartz R., Jennson O., Arnason A., Borresen A-L., Heiberg A., Frey D., Steinmann В. (1990). Consistent linkage of dominantly inherited osteogenesis imperfecta to the type I collagen loci: COL1A1 and COL1A2. Am. J. Hum. Genet. 46: 293-307.
Willing M.C., Pruchno C.J., Atkinson M., Beyers P.M. (1992). Osteogenesis imperfecta type I is commonly due to a COL1A1 null allele of type I collagen. Am. J. Hum. Genet. 51: 508-515.
Willing M.C., Slayton R.L., Pitts S.H., Deschenes S.P. (1995). Absence of mutations in the promoter of COL1A1 gene of type I collagen in patients with osteogenesis imperfecta type I. J. Med. Genet. 32: 697-700.
Yang Y.G., Osterman H. (1997). Detection of human mutation using Base Excision Sequence Scanning (BESS) and the Li COR IR2 Automated Sequencer. Epicentre Forum 4(4).